Seminars in Thoracic and Cardiovascular Surgery
Volume 17, Issue 4 , Pages 284-291 , Winter 2005

Epidemiology and Molecular Biology of Barrett Esophagus

  • Alan G. Casson (FRCSC)

      Affiliations

    • Department of Surgery (Division of Thoracic Surgery), Dalhousie University and the QEII Health Sciences Centre, Halifax, Nova Scotia, Canada.
    • Department of Pathology (Division of Molecular Pathology and Molecular Genetics), Dalhousie University; and the QEII Health Sciences Centre, Halifax, Nova Scotia, Canada.
    • Corresponding Author InformationAddress reprint requests to A.G. Casson, FRCSC, Division of Thoracic Surgery, QE II Health Sciences Centre, Victoria Building 7S-013, 1278 Tower Road, Halifax, Nova Scotia, Canada B3H 2Y9.
    • ,
  • Lara Williams, MD

      Affiliations

    • Department of Surgery (Division of Thoracic Surgery), Dalhousie University and the QEII Health Sciences Centre, Halifax, Nova Scotia, Canada.
    • ,
  • Duane L. Guernsey, PhD

      Affiliations

    • Department of Surgery (Division of Thoracic Surgery), Dalhousie University and the QEII Health Sciences Centre, Halifax, Nova Scotia, Canada.
    • Department of Pathology (Division of Molecular Pathology and Molecular Genetics), Dalhousie University; and the QEII Health Sciences Centre, Halifax, Nova Scotia, Canada.

References 

  1. Blot WJ , McLaughlin JK . The changing epidemiology of esophageal cancer . Semin Oncol . 1999;26:2–8
  2. Botterweck AAM , Schouten LJ , Volovics A , et al.   Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries . Int J Epidemiol . 2000;29:645–654
  3. Powell J , McConkey CC , Gillison EW , et al.   Continuing rising trend in oesophageal adenocarcinoma . Int J Cancer . 2002;102:422–427
  4. Mayne ST , Navarro SA . Diet, obesity and reflux in the etiology of adenocarcinomas of the esophagus and gastric cardia in humans . J Nutr . 2002;132:3467S–3470S
  5. Forman D . Oesophago-gastric adenocarcinoma—an epidemiological perspective . Aliment Pharmacol Ther . 2004;20:55–60
  6. Lagergren J . Adenocarcinoma of oesophagus (what exactly is the size of the problem and who is at risk?) . Gut . 2005;54:1–5
  7. Wong A , Fitzgerald RC . Epidemiologic risk factors for Barrett’s esophagus and associated adenocarcinoma . Clin Gastroenterol Hepatol . 2005;3:1–10
  8. Kuczmarski RJ , Flegal KM , Campbell SM , et al.   Increasing prevalence of overweight among US adultsThe national health and nutrition examination surveys,1960-1991 . JAMA . 1994;272:205–211
  9. Seidell JC , Flegal KM . Assessing obesity (classification and epidemiology) . Br Med Bull . 1997;53:238–252
  10. Calle EE , Rodriguez C , Walker-Thurmond K , et al.   Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults . N Engl J Med . 2003;348:1625–1638
  11. Brown LM , Swanson CA , Gridley G , et al.   Adenocarcinoma of the esophagus (role of obesity and diet) . J Natl Cancer Inst . 1995;87:104–109
  12. Vaughan TL , Davis S , Kristal A , et al.   Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia (adenocarcinoma versus squamous cell carcinoma) . Cancer Epidemiol Biomark Prev . 1995;4:85–92
  13. Chow W-H , Blot WJ , Vaughan TL , et al.   Body mass index and risk for adenocarcinoma of the esophagus and gastric cardia . J Natl Cancer Inst . 1998;90:150–155
  14. Lagergren J , Bergstrom R , Nyren O . Association between body mass and adenocarcinoma of the esophagus and cardia . Ann Intern Med . 1999;130:883–890
  15. Wu AH , Wan P , Bernstein L . A multiethnic population-based study of smoking, alcohol and body size and risk of adenocarcinomas of the stomach and esophagus (United States) . Cancer Causes Control . 2001;12:721–732
  16. Engel LS , Chow W-H , Vaughan TL , et al.   Population attributable risks of esophageal and gastric cancers . J Natl Cancer Inst . 2003;95:1404–1413
  17. Chow W-H , Finkle WD , McLaughlin JK , et al.   The relation of gastroesophageal reflux disease and its treatment to adenocarcinomas of the esophagus and gastric cardia . JAMA . 1995;274:474–477
  18. Farrow DC , Vaughn TL , Sweeney C , et al.   Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer . Cancer Causes Control . 2000;11:231–238
  19. Lagergren J , Bergstrom R , Lindgren A , et al.   Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma . N Engl J Med . 1999;340:825–831
  20. Zhang Z-F , Kurtz RC , Yu G-P , et al.   Adenocarcinomas of the esophagus and gastric cardia (the role of diet) . Nutr Cancer . 2001;10:1055–1062
  21. Terry P , Lagergren J , Ye W , et al.   Antioxidants and cancers of the esophagus and gastric cardia . Int J Cancer . 2000;87:750–754
  22. Mayne ST , Risch HA , Dubrow R , et al.   Nutrient intake and risk of subtypes of esophageal and gastric cancer . Cancer Epidemiol Biomark Prev . 2001;10:1055–1062
  23. Zhang Z-F , Kurtz RC , Sun M , et al.   Adenocarcinomas of the esophagus and gastric cardia (medical conditions, tobacco, alcohol and socioeconomic factors) . Cancer Epidemiol Biomark Prev . 1996;5:761–768
  24. Gammon MD , Schoenberg JB , Ahsan H , et al.   Tobacco, alcohol and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia . J Natl Cancer Inst . 1997;89:1277–1284
  25. Enzinger PC , Mayer RJ . Esophageal cancer . N Engl J Med . 2003;349:2241–2252
  26. Specher SJ . Clinical practice. Barrett’s esophagus . N Engl J Med . 2002;346:836–842
  27. Jankowski JA , Wright NA , Meltzer SJ , et al.   Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus . Am J Pathol . 1999;154:965–973
  28. Shaheen N , Ransohoff DF . Gastroesophageal reflux, Barrett’s esophagus and esophageal cancer . JAMA . 2002;287:1972–1981
  29. Casson AG . Role of molecular biology in the follow-up of patients who have Barrett’s esophagus . Chest Surg Clin N Am . 2002;12:93–111
  30. Reid BJ , Blount PL , Rabinovitch PS . Biomarkers in Barrett’s esophagus . Gastrointest Clin N Am . 2003;13:369–397
  31. McManus DT , Olaru A , Meltzer SJ . Biomarkers of esophageal adenocarcinoma and Barrett’s esophagus . Cancer Res . 2004;64:1561–1569
  32. Sampliner RE . Practice guidelines on the diagnosis, surveillance, and therapy of Barrett’s esophagus . Am J Gastroenterol . 1998;93:1028–1032
  33. Spechler SJ . Columnar-lined esophagus. Definitions . Chest Surg Clin N Am . 2002;12:1–13
  34. Haggitt RC . Barrett’s esophagus, dysplasia, and adenocarcinoma . Hum Pathol . 1994;25:983–993
  35. Antonelli DA , Wang HH . Morphology of Barrett’s esophagus and Barrett’s-associated dysplasia and adenocarcinoma . Gastroenterol Clin N Am . 1997;26:495–506
  36. Oberg S , DeMeester TR , Peters JH , et al.   The extent of Barrett’s esophagus depends on the status of the lower esophageal sphincter and the degree of acid exposure . J Thorac Cardiovasc Surg . 1999;117:572–580
  37. DeMeester SR , DeMeester TR . Columnar mucosa and intestinal metaplasia of the esophagus. Fifty years of controversy . Ann Surg . 2000;3:303–321
  38. Spechler SJ , Zeroogian JM , Antonioli DA , et al.   Prevalence of metaplasia at the gastro-oesophageal junction . Lancet . 1994;344:1533–1536
  39. Spechler SJ . Short and ultrashort Barrett’s esophagus (what does it mean?) . Semin Gastrointest Dis . 1997;8:59–67
  40. Clark GWB , Smyrk TC , Burdiles P , et al.   Is Barrett’s metaplasia the source of adenocarcinomas of the cardia? . Arch Surg . 1994;129:609–614
  41. Ruol A , Parenti A , Zaninotto G , et al.   Intestinal metaplasia is the probable common precursor of adenocarcinoma in Barrett esophagus and adenocarcinoma of the gastric cardia . Cancer . 2000;88:2520–2528
  42. Ormsby AH , Vaezi MF , Richter JE , et al.   Cytokeratin immunoreactivity patterns in the diagnosis of short-segment Barrett’s esophagus . Gastroenterology . 2000;119:683–690
  43. McArdle JE , Lewin KJ , Randall G , et al.   Distribution of dysplasias and early invasive carcinoma in Barrett’s esophagus . Hum Pathol . 1992;23:479–482
  44. Buttar NS , Wang KK , Sebo TJ , et al.   Extent of high-grade dysplasia in Barrett’s esophagus correlates with risk of adenocarcinoma . Gastroenterology . 2001;120:1630–1639
  45. Schnell TG , Sontag SJ , Chejfec G , et al.   Long-term nonsurgical management of Barrett’s esophagus with high-grade dysplasia . Gastroenterology . 2001;120:1607–1619
  46. Anderson LA , Murray LJ , Murphy SJ , et al.   Mortality in Barrett’s oesophagus (results from a population based study) . Gut . 2003;52:1081–1084
  47. Siewert JR , Stein HJ . Classification of adenocarcinoma of the oesophagogastric junction . Br J Surg . 1998;85:1457–1459
  48. Casson AG , Mukhopadhyay T , Cleary KR , et al.   p53 gene mutations in Barrett’s epithelium and esophageal cancer . Cancer Res . 1991;51:4495–4499
  49. Pera M . Trends in incidence and prevalence of specialized intestinal metaplasia, Barrett’s esophagus, and adenocarcinoma of the gastroesophageal junction . World J Surg . 2003;27:999–1008
  50. Grupo Operativo per lo Studio delle Precancerosi dell’Esofago (GOSPE) . Barrett’s esophagus (epidemiological and clinical results of a multicentric survey) . Int J Cancer . 1991;48:364–368
  51. Cameron AJ . Epidemiology of columnar-lined esophagus and adenocarcinoma . Gastroenterology Clin N Am . 1997;26:487–494
  52. Cameron AJ , Lomboy CT . Barrett’s esophagus (age, prevalence and extent of columnar epithelium) . Gastroenterology> . 1992;103:1241–1245
  53. Bonelli L . Barrett’s esophagus (results of a multicentric survey) . Endoscopy . 1993;103:652–654
  54. Johnston MH , Hammond AH , Laskin W , et al.   The prevalence and clinical characteristics of short segments of specialized intestinal metaplasia in the distal esophagus on routine endoscopy . Am J Gastroenterol . 1996;91:1507–1511
  55. Cameron AJ , Zinsmeister AR , Ballard DJ , et al.   Prevalence of columnar-lined (Barrett’s) esophagus. Comparison of population-based and autopsy findings . Gastroenterology . 1990;99:918–922
  56. Conio M , Cameron AJ , Romero Y , et al.   Secular trends in the epidemiology and outcomes of Barrett’s oesophagus in Olmsted County, Minnesota . Gut . 2001;48:304–309
  57. Prach AT . Increasing incidence of Barrett’s esophagus (education, enthusiasm, or epidemiology?) . Lancet . 1997;350:933
  58. Caygill CPJ , Reed PI , Johnston BJ , et al.   A single centre’s 20 year experience of columnar-lined (Barrett’s) oesophagus diagnosis . Eur J Gastroenterol Hepatol . 1999;11:1355–1358
  59. Sharma P , Morales TG , Sampliner RE . Short segment Barrett’s esophagus (the need for standardization and the definition of endoscopic criteria) . Am J Gastroenterol . 1998;93:1033–1036
  60. Hirota WK , Loughney TM , Lazas DJ , et al.   Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction (prevalence and clinical data) . Gastroenterology . 1999;116:277–285
  61. Sharma P , Weston P , Morales T , et al.   Relative risk of dysplasia for patients with intestinal metaplasia in the distal oesophagus and on the gastric cardia . Gut . 2000;46:9
  62. Sharma P , Morales T , Bhattacharia A , et al.   Dysplasia in short segment Barrett’s esophagus (a prospective 3-year follow-up) . Am J Gastroenterol . 1997;92:2012–2016
  63. Champion G , Richter JE , Vaezi MF , et al.   Duodenogastroesophageal reflux (relationship to pH and importance in Barrett’s esophagus) . Gastroenterology . 1994;107:747–754
  64. Goldstein SR , Yang G , Curtis SK , et al.   Development of esophageal metaplasia and adenocarcinoma in a rat surgical model without the use of a carcinogen . Carcinogenesis . 1997;18:2265–2270
  65. Vaezi MF , Richter JE . Bile reflux in columnar-lined esophagus . Gastroenterol Clin North Am . 1997;26:565–582
  66. Reid BJ , Blount PL , Rubin CE , et al.   Flow-cytometric and histological progression to malignancy in Barrett’s esophagus (prospective endoscopic surveillance of a cohort) . Gastroenterology . 1992;102:1212–1219
  67. Gray MR , Hall PA , Nash J , et al.   Epithelial proliferation in Barrett’s esophagus by proliferating cell nuclear antigen immunolocalization . Gastroenterology . 1992;103:1769–1776
  68. Gillen P , McDermott M , Grehan D , et al.   Proliferating cell nuclear antigen in the assessment of Barrett’s mucosa . Br J Surg . 1994;81:1766–1768
  69. Hong MK , Laskin WB , Herman BE , et al.   Expansion of the Ki-67 proliferative compartment correlates with degree of dysplasia in Barrett’s esophagus . Cancer . 1995;75:423–429
  70. Chalasani N , Wo JM , Hunter JG , et al.   Significance of intestinal metaplasia in different areas of the esophagus including the esophagogastric junction . Dig Dis Sci . 1997;42:603–607
  71. Richter JE . Intestinal metaplasia and the squamocolumnar junction (what does it all mean?) . Gut . 1998;42:604–605
  72. Chen YY , Antonioli DA , Spechler SJ , et al.   Gastroesophageal reflux disease versus Helicobacter pylori infection as the cause of gastric carditis . Mod Pathol . 1998;11:950–956
  73. Vaezi MF , Falk GW , Peek RM , et al.   CagA-positive strains of Helicobacter pylori may protect against Barrett’s esophagus . Am J Gastroenterol . 2000;95:2206–2211
  74. Trudgill N . Familial factors in the etiology of gastroesophageal reflux disease, Barrett’s esophagus, and esophageal adenocarcinoma . Chest Surg Clin N Am . 2002;12:15–24
  75. Sartori S , Nielsen I , Indelli M , et al.   Barrett esophagus after chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) (an iatrogenic injury?) . Ann Int Med . 1991;114:210–211
  76. McKinley M , Sherlock P . Barrett’s esophagus with adenocarcinoma in scleroderma . Am J Gastroenterol . 1984;79:438–439
  77. Spechler SJ , Schimmell EM , Dalton JW . Barrett’s esophagus complicating lye ingestion with sparing of the distal esophagus . Gastroenterology . 1981;81:580–583
  78. Meyer W , Vollmar F , Bar W . Barrett’s esophagus following total gastrectomy . Endoscopy . 1979;2:121–126
  79. Kortan P , Warren RE , Gardner J , et al.   Barrett’s esophagus in a patient with surgically resected achalasia . J Clin Gastroenterol . 1981;3:357–360
  80. Hayes DF , Bast RC , Desch CE , et al.   Tumor marker utility grading system (a framework to evaluate clinical utility of tumor markers) . J Natl Cancer Inst . 1996;88:1456–1466
  81. Pepe MS , Etziomi R , Feng Z , et al.   Phases of biomarker development for early detection of cancer . J Natl Cancer Inst . 2001;93:1054–1061
  82. Menke-Pluymers MB , Mulder AH , Hop WC , et al.  The Rotterdam Oesophageal Tumor Study Group   Dysplasia and aneuploidy as markers of malignant degeneration in Barrett’s esophagus . Gut . 1994;35:1348–1351
  83. Galipeau PC , Cowan DS , Sanchez CA , et al.   17p (p53) allelic losses, 4N (G2/tetraploid) populations, and progression to aneuploidy in Barrett’s esophagus . Proc Natl Acad Sci USA . 1996;93:7081–7084
  84. Montgomery EA , Hartmann DP , Carr NJ , et al.   Barrett esophagus with dysplasia. Flow cytometric DNA analysis of routine, paraffin-embedded mucosal biopsies . Am J Clin Pathol . 1996;106:298–304
  85. Tedori L , Gohde W , Persiani M , et al.   DNA/protein flow cytometry as a predictive marker of malignancy in dysplasia-free Barrett’s esophagus (thirteen-year follow-up study of a cohort of patients) . Cytometry . 1998;34:257–263
  86. Reid BJ , Blount PL , Feng Z , et al.   Optimizing endoscopic biopsy detection of early cancers in Barrett’s high-grade dysplasia . Am J Gastroenterol . 2000;95:3089–3096
  87. Reid BJ , Levine DS , Longton G , et al.   Predictors of progression to cancer in Barrett’s esophagus (Baseline histology and flow cytometry identify low- and high-risk patient subsets) . Am J Gastroenterol . 2000;95:1669–1676
  88. Reid BJ , Prevo LJ , Galipeay PC , et al.   Predictors of progression in Barrett’s esophagus II (Baseline 17p (p53) loss of heterozygosity identifies a patient subset at increased risk for neoplastic progression) . Am J Gastroenterol . 2001;96:2839–2848
  89. Rabinovitch PS , Longton G , Blount PL , et al.   Predictors of progression in Barrett’s esophagus III (baseline flow cytometric variables) . Am J Gastroenterol . 2001;96:3071–3083
  90. Raskind WH , Norwood TH , Levine DS , et al.   Persistent clonal areas and clonal expansion in Barrett’s esophagus . Cancer Res . 1992;52:2946–2950
  91. Barrett MT , Sanchez CA , Prevo LJ , et al.   Evolution of neoplastic cell lineages in Barrett oesophagus . Nat Genet . 1999;22:106–109
  92. Nakamura T , Nekarda H , Holscher AH , et al.   Prognostic value of DNA ploidy and c-erb-B2 oncoprotein expression in adenocarcinoma of Barrett’s esophagus . Cancer . 1994;73:1785–1794
  93. Sarbia M , Molsberger G , Willers R , et al.   The prognostic significance of DNA ploidy in adenocarcinomas of the esophagogastric junction . J Cancer Res Clin Oncol . 1996;122:186–188
  94. Gleeson CM , Sloan JM , McManus DT , et al.   Comparison of p53 and DNA content abnormalities in adenocarcinoma of the esophagus and gastric cardia . Br J Cancer . 1998;77:277–286
  95. Chanvitan A , Puttawibul P , Casson AG . Flow cytometry in squamous cell esophageal cancer and precancerous lesions . Dis Esophagus . 1997;10:206–210
  96. Prives C , Hall PA . The p53 pathway . J Pathol . 1999;187:112–116
  97. Sengupta S , Harris CC . p53 (traffic cop at the crossroads of DNA repair and recombination) . Nat Rev . 2005;6:44–55
  98. Harris CC . Structure and function of the p53 tumor suppressor gene (clues for rational cancer therapeutic strategies) . J Natl Cancer Inst . 1996;88:1442–1445
  99. Wallace-Brodeur RR , Lowe SW . Clinical implications of p53 mutations . Cell Mol Life Sci . 1999;54:64–75
  100. Casson AG , Mukhopadhyay T , Cleary KR , et al.   p53 gene mutations in Barrett’s epithelium and esophageal cancer . Cancer Res . 1991;51:4495–4499
  101. Schneider PM , Casson AG , Levin B , et al.   Mutations of p53 in Barrett’s esophagus and Barrett’s cancer (a prospective study of 98 cases) . J Thorac Cardiovasc Surg . 1996;111:323–333
  102. Casson AG , Evans SC , Gillis A , et al.   Clinical implications of p53 tumor suppressor gene mutation and protein expression in esophageal adenocarcinoma (results of a 10-year prospective study) . J Thorac Cardiovasc Surg . 2003;125:1121–1131
  103. Murray AW . Recycling the cell cycle (cyclins revisited) . Cell . 2004;116:221–234
  104. Arber N , Lightdale C , Rotterdam H , et al.   Increased expression of the cyclin D1 gene in Barrett’s esophagus . Cancer Epidemiol Biomark Prev . 1996;5:457–459
  105. Bani-Hani K , Martin IG , Hardie LJ , et al.   Prospective study of cyclin D1 overexpression in Barrett’s esophagus (association with increased risk of adenocarcinoma) . J Natl Cancer Inst . 2000;92:1316–1321
  106. Betticher DC , Thatcher N , Altermatt HJ , et al.   Alternate splicing produces a novel cyclin D1 transcript . Oncogene . 1995;11:1005–1011
  107. Solomon DA , Wang Y , Fox SR , et al.   Cyclin D1 splice variants. Differential effects on localization, RB phosphorylation, and cellular transformation . J Biol Chem . 2003;278:30339–30347
  108. Lu F , Gladden AB , Diehl JA . An alternatively spliced cyclin D1 isoform, cyclin D1b, is a nuclear oncogene . Cancer Res . 2003;63:7056–7061
  109. Casson AG , Zheng Z , Evans SC , et al.   Cyclin D1 polymorphism G870A and risk for esophageal adenocarcinoma . Cancer . 2005;104:730–739
  110. Xing EP , Nie Y , Song Y , et al.   Mechanisms of inactivation of p14ARF, p15INK4b, and p16INK4a genes in human esophageal squamous cell carcinoma . Clin Cancer Res . 1999;5:2704–2713
  111. Maley CC , Galipeau PC , Li X , et al.   Selectively advantageous mutations and hitchhikers in neoplasma (p16 lesions are selected in Barrett’s esophagus) . Cancer Res . 2004;64:3414–3427
  112. Hardie LJ , Darnton SJ , Wallis YL , et al.   p16 expression in Barrett esophagus and esophageal adenocarcinoma (association with genetic and epigenetic alterations) . Cancer Lett . 2005;217:221–230

 Supported in part by the Nova Scotia Health Research Foundation; the Capital Health Research Fund; and the National Cancer Institute of Canada with funds from the Canadian Cancer Society. A.G.C. is supported by a Senior Clinical Research Scholarship from the Dalhousie University Faculty of Medicine.

PII: S1043-0679(05)00079-1

doi: 10.1053/j.semtcvs.2005.09.005

Seminars in Thoracic and Cardiovascular Surgery
Volume 17, Issue 4 , Pages 284-291 , Winter 2005

Article Tools